EWA
PROK icon

EverSource Wealth Advisors’s ProKidney PROK Stock Holding History

EverSource Wealth Advisors’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-38
Closed -$92 – 4402
2025
Q3 		$92 Sell
38
-979
-96% -$2.61K ﹤0.01% 4208
2025
Q2 		$602 Buy
1,017
+750
+281% +$584 ﹤0.01% 3856
2025
Q1 		$234 Buy
267
+230
+622% +$319 ﹤0.01% 3673
2024
Q4 		$63 Buy
+37
New +$67 ﹤0.01% 3613

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return

EverSource Wealth Advisors's PROK Position: Q4 2025 in Review

EverSource Wealth Advisors sold out of ProKidney (PROK) in Q4 2025, closing a stake of 38 shares — an estimated $92 sold.

EverSource Wealth Advisors first reported a position in PROK in Q4 2024 and held it in 4 quarters. The position peaked at $602 in Q2 2025. 63 funds tracked by Wall St. Rank hold PROK as of Q4 2025.

  • EverSource Wealth Advisors reported no remaining ProKidney position as of Q4 2025 after selling out during the quarter.
  • EverSource Wealth Advisors sold 38 ProKidney shares in Q4 2025, an estimated $92.
  • EverSource Wealth Advisors first reported a position in ProKidney in Q4 2024 and held it in 4 quarters.
  • EverSource Wealth Advisors's ProKidney position peaked at $602 in Q2 2025.
  • 63 funds tracked by Wall St. Rank held ProKidney as of Q4 2025.

Based on EverSource Wealth Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.